- Report
- February 2024
- 200 Pages
Global
From €4797EUR$5,000USD£4,132GBP
- Report
- January 2024
- 175 Pages
Global
From €4797EUR$5,000USD£4,132GBP
- Report
- January 2024
- 175 Pages
Global
From €4797EUR$5,000USD£4,132GBP
- Report
- January 2024
- 200 Pages
Global
From €4797EUR$5,000USD£4,132GBP
- Report
- December 2023
- 200 Pages
Global
From €4797EUR$5,000USD£4,132GBP
- Report
- November 2023
- 250 Pages
Global
From €4797EUR$5,000USD£4,132GBP
- Report
- November 2023
- 250 Pages
Global
From €4797EUR$5,000USD£4,132GBP
- Report
- November 2023
- 250 Pages
Global
From €4797EUR$5,000USD£4,132GBP
- Report
- March 2024
- 138 Pages
Global
From €2877EUR$2,999USD£2,478GBP
- Report
- September 2023
- 149 Pages
Global
From €2398EUR$2,499USD£2,065GBP
- Report
- June 2023
- 195 Pages
Global
From €2389EUR$2,490USD£2,058GBP
- Report
- February 2024
- 200 Pages
Global
From €1823EUR$1,900USD£1,570GBP
- Report
- February 2024
- 115 Pages
Global
From €4558EUR$4,750USD£3,925GBP
- Report
- February 2024
- 170 Pages
Global
From €4701EUR$4,900USD£4,049GBP
- Report
- January 2024
- 175 Pages
Global
From €4701EUR$4,900USD£4,049GBP
- Report
- January 2024
- 188 Pages
Global
From €4701EUR$4,900USD£4,049GBP
- Report
- October 2023
- 190 Pages
Global
From €4701EUR$4,900USD£4,049GBP
- Report
- October 2023
- 189 Pages
Global
From €4701EUR$4,900USD£4,049GBP
- Report
- October 2023
- 177 Pages
Global
From €4701EUR$4,900USD£4,049GBP
- Report
- October 2023
- 171 Pages
Global
From €4701EUR$4,900USD£4,049GBP
Diabetic Retinopathy (DR) is a medical condition that affects the eyes of people with diabetes. It is caused by damage to the blood vessels in the retina, the light-sensitive layer of tissue at the back of the eye. DR can lead to vision loss and blindness if left untreated.
Optical imaging technologies, such as optical coherence tomography (OCT) and fundus photography, are used to diagnose and monitor DR. These technologies allow for early detection and treatment of DR, which can help to reduce the risk of vision loss.
In addition to imaging technologies, there are a number of treatments available for DR, including laser photocoagulation, intravitreal injections, and vitrectomy. These treatments can help to reduce the risk of vision loss and improve vision in those with DR.
The DR market is a rapidly growing market, driven by the increasing prevalence of diabetes and the need for early detection and treatment of DR.
Companies in the DR market include Carl Zeiss Meditec, Topcon Corporation, Optos, Nidek, and Heidelberg Engineering. Show Less Read more